Complex | |
AACDB_ID: | 1267 |
PDBID: | 5DMJ |
Chains: | F_G |
Organism: | Homo sapiens |
Method: | XRD |
Resolution (Å): | 2.79 |
Reference: | 10.1016/j.jmb.2016.05.014 |
Antibody | |
Antibody: | 3H56-5 VH-sdAb |
Antibody mutation: | No |
INN (Clinical Trial): | |
Antigen | |
Antigen: | Tumor necrosis factor receptor superfamily member 5(extracellular domain of the CD40) |
Antigen mutation: | No |
Durg Target: |
Antibody
Chain: F
Mutation: NULL
>5DMJ_F|Chain A, C[auth D], E[auth F]|Tumor necrosis factor receptor superfamily member 5|Homo sapiens (9606) PTACREKQYLINSQCCSLCQPGQKLVSDCTEFTETECLPCGESEFLDTWNRETHCHQHKYCDPNLGLRVQQKGTSETDTICTCEEGWHCTSEACESCVLHRSCSPGFGVKQIATGVSDTICEPCPVGFFSDVSSAFEKCHPWTSCETKDLVVQQAGTDKTDVVCGPQDRLRDPGGGGGRLVPR |
Antigen
Chain: G
Mutation: NULL
>5DMJ_G|Chain B, D[auth E], F[auth G]|3H65-5 domain antibody (dAb)|Homo sapiens (9606) STEVQLLESGGGLVQPGGSLRLSCAASGFTFRDYEMWWVRQAPGKGLERVSAINPQGTRTYYADSVMGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKLPFTFDDWGQGTLVTVSSAAA |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
F: PRO85 ASN86 LEU87 GLY88 GLU106 GLU107 GLY108 TRP109 CYS119 VAL120 LEU121 HIS122 SER124 GLN133 ILE134 THR136 PHE151 VAL154 SER155 SER156 ALA157 PHE158 GLU159 HIS162 G: GLU33 TRP35 VAL37 GLY44 LEU45 ARG47 ALA50 ILE51 PRO52 ARG56 THR57 TYR58 ALA93 LEU95 PRO96 PHE97 THR98 PHE99 TRP103 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)